Table 2.
Multivariate Regression Results*
| General Innovativeness | Medical Technology Innovativeness | Device Vignette | Drug Vignette | |
|---|---|---|---|---|
| Black race | −0.06 (−0.26,0.15) | −0.24† (−0.42,−0.06) | 0.11 (−0.11,0.34) | −0.36† (−0.64,−0.08) |
| Female | 0.29 (−0.16,0.73) | 0.56‡ (0.17, 0.96) | 0.30 (−0.32, 0.91) | −0.21 (−0.70,0.28) |
| Age | −0.18 (−0.39, 0.02) | −0.06 (−0.23,0.12) | −0.15 (−0.37,0.08) | −0.31† (−0.58,−0.04) |
| Income <$20,000 per year | 0.07 (−0.11,0.30) | −0.14 (−0.32,0.05) | −0.001 (−0.25,0.25) | 0.03 (−0.22,0.29) |
| Education <high school diploma | −0.08 (−0.32,0.22) | −0.08 (−0.30,0.14) | −0.03 (−0.34,0.29) | −0.10 (−0.42,0.22) |
| More than 2 comorbid conditions | 0.08 (−0.14,0.31) | 0.14 (−0.05,0.34) | 0.52‡ (0.26,0.76) | 0.05 (−0.26,0.35) |
| History of cardiovascular disease | −0.08 (−0.31,0.14) | 0.01 (−0.19,0.21) | −0.14 (−0.39, 0.12) | 0.05 (−0.24, 0.34) |
| Less than 2 prior procedures | −0.08 (−0.30,0.14) | −0.08 (−0.28,0.11) | −0.01 (−0.26,0.23) | 0.11 (−0.18,0.40) |
| Risk attitude | 0.22‡ (0.14,0.29) | 0.16‡ (0.09,0.23) | 0.14‡ (0.05,0.23) | 0.12† (0.02,0.22) |
*
Coefficients indicate the expected change in innovativeness score for patients in each category versus patients not in each category (for age, expected change in innovativeness score per additional 10 years of age; for risk attitude, expected change in innovativeness score with a unit increase in risk-tolerance score).
†
P<.05
‡
P<.01.